GERN — GERON CORP

—
Nasdaq · Health Care · Pharmaceuticals · CIK 886744 ·
Last close
$1.00
Market Cap
$644.24M
52W High
$2.01
52W Low
$0.84
ADV30
14,593,794
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 60,190,000 54,139,000 5,728,000 1,350,000 527,106,000 69,179,000 300,411,000
Jun 2026 57,480,000 48,240,000 -12,653,000 -16,680,000 519,009,000 62,643,000 300,395,000
Mar 2026 51,837,000 50,145,000 -236,000 -3,642,000 534,120,000 68,895,000 305,012,000
Dec 2025 48,015,000 46,709,000 -8,508,000 -28,862,000 570,540,000 77,560,000 344,668,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-90,533,000
Investing CF
$75,386,000
Financing CF
$6,354,000
CapEx
$-629,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.08
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,874,813,000
Inventory
$126,603,000
Receivables
$48,007,000
ST Investments
$217,300,000
EBIT TTM
$-19,037,000
Pretax Income TTM
$-47,834,000
Interest Exp TTM
$28,797,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$217,522,000
EBITDA
$-15,175,000
Free Cash Flow
$-59,214,248
Enterprise Value
$472,416,608
Total Cash
$286,479,008
Total Debt
$121,228,000
Shares Out
644,238,859
Trailing EPS
$-0.08
Book Value
$0.35
ROE
-20.1%
ROA
-1.8%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 183,881,000 -51,553,000 -83,500,000 570,540,000 344,668,000 225,872,000 -111,037,000
Dec 2024 76,994,000 -173,732,000 -174,572,000 593,781,000 313,461,000 280,320,000 -218,618,000
Dec 2023 237,000 -193,944,000 -184,127,000 394,076,000 146,127,000 247,949,000 -167,743,000
Dec 2022 596,000 -138,550,000 -141,901,000 190,575,000 110,577,000 79,998,000 -127,379,000

TTM Snapshot

Revenues TTM
$38,795,000
NetIncome TTM
$-67,612,000
OpCashFlow TTM
—
Assets (Latest)
$519,009,000
Forward EPS
$0.04

Peers — same industry

TickerNameMarket CapLastDaily %
SVA SINOVAC BIOTECH LTD $642.44M $6.47 —
BCAX Bicara Therapeutics Inc. $637.32M $9.60 —
JANX Janux Therapeutics, Inc. $655.27M $10.71 —
OLMA Olema Oncology, Inc. $632.52M $7.22 —
DSGN Design Therapeutics, Inc. $630.12M $9.84 —

News headlines (Yahoo Finance, 1h cache)

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-18 21:05 · Yahoo
Geron Targets Germany Launch and Deals as RYTELO Sales Grow
2026-11-11 04:14 · Yahoo
What Investors Got Wrong About Geron Before The Drop
2026-11-08 23:15 · Yahoo
Geron: 3 Key Takeaways for Long-Term Investors
2026-11-05 12:14 · Yahoo
Geron Corp (GERN) Q3 2026 Earnings Call Transcript
2026-11-05 03:13 · Yahoo
Geron Corp (GERN) Q3 2026 Earnings Call Highlights: RYTELO Revenue Climbs 27% as Cost Cuts Lift ...
2026-11-04 23:07 · Yahoo
Geron Corporation Q3 2026 Earnings Call Summary
2026-11-04 18:42 · Yahoo
Geron Q3 Earnings Call Highlights
2026-11-04 17:14 · Yahoo
Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026
2026-11-04 14:00 · Yahoo
Geron (GERN) Reports Break-Even Earnings for Q3
2026-11-04 12:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.